Please login to the form below

Not currently logged in


This page shows the latest Abraxane news and features for those working in and with pharma, biotech and healthcare.

Celgene joins PD-1 race via partnership with BeiGene

Celgene joins PD-1 race via partnership with BeiGene

BeiGene is also acquiring Celgene's commercial operations in Asia with the right to sell blood cancer therapies Revlimid (lenalidomide) and Vidaza (azacitidine) and Abraxane (albumin-bound paclitaxel) for pancreatic cancer -

Latest news

More from news
Approximately 15 fully matching, plus 28 partially matching documents found.

Latest from PMHub

  • Marketing strategy in complex environments

    cells. A good example of this is the combined use of  Abraxane and  gemcitabine in the treatment of  metastatic adenocarcinoma of the pancreas – Abraxane helps to inhibit cancer cell growth, and

  • Serviceplan Health & Life

    Our network has helped launch or is launching these brands across multiple markets: Abraxane, Cimzia, Eliquis, Elotuzumab, Extavia, Gilenya, Intelence, Lonsurf, Lonquex, Spiriva, Toctino, Votrient, VX-809, and Xeomin.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Lucid Group Communications Limited

We are industry-leading thinkers when it comes to education. We use the latest academic thinking on the psychology of behaviour...

Latest intelligence

Tools for the digital world
The next step for the pharma industry...
How Can We Make Payer Communications Really Sing?
With so many different influences at play in access decisions, how can we make sure we tap into what’s really driving payer decision-making. How do we go beyond the stated...
Harnessing the power of core elements to optimise market access
This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...